Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Scientists have mapped how over 140,000 mutations affect the formation of amyloid beta fibrils, offering an unprecedented look at early events in Alzheimer’s disease.

By analyzing thousands of Aβ42 peptides, the scientists gained a better understanding of how mutations in Aβ affect protein ...

"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the first participant has been dosed in the global Phase 3 ...

Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D., effective June 20, 2025 -- ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

A new system from DNA Protocol, called the Genomic Hash Mesh, now secures human DNA as a verifiable, on-chain identity anchor ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases ...